The molecular mechanisms associated with resistance to chemotherapy in ovarian cancer include increased activity of the drug efflux pump mediated by the multidrug resistance protein 1 (MDR-1, also known as P-gp), increased repair capacity of DNA damage, decreased drug intake, and decreased apoptosis, as well as drug-induced cell cycle arrest (38). This evidence concerns the gene ABCB1 and ovarian cancer.